NLRP7 Mutation analysis in sporadic hydatidiform moles in tunisian patients: NLRP7 and sporadic mole

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 6, 2012, Pages 646-651

  Landolsi, Hanne ^a,b,d   Rittore, Cecile ^c   Philibert, Laurent ^c   Hmissa, Sihem ^a,b   Gribaa, Moez ^a   Touitou, Isabelle ^c   Yacoubi, Mohamed Tahar ^a,b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF SOUSSE   (Tunisia)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

NLRP7 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; DNA SEQUENCE; FEMALE; GENETICS; HOMOZYGOTE; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREGNANCY; TUNISIA; UTERUS CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; HOMOZYGOTE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; PREGNANCY; SEQUENCE ANALYSIS, DNA; TUNISIA; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 84864199343     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0399-OA     Document Type: Article

References (41)

1. Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003;110(1):22-26. (Pubitemid 36034289)
2. Szulman AE, Surti U. The syndromes of hydatidiform mole, II: morphologic evolution ofthe complete and partial mole. Am J Obstet Gynecol. 1978;132(1):20-27. (Pubitemid 8397361)
3. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29(7):942-947. (Pubitemid 40885018)
4. Castrillon DH, Sun D, Weremowicz S, Fisher RA, Crum CP, Genest DR. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001;25(10):1225-1230. (Pubitemid 32917114)
5. Landolsi H, Missaoui N, Brahem S, Hmissa S, Gribaa M, Yacoubi MT. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole. Pathol Res Pract. 2011;207(8):498-504.
6. Murphy KM, McConnell TG, Hafez MJ, Vang R, Ronnett BM. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn. 2009;11(6):598-605.
7. Landolsi H, Missaoui N, Yacoubi MT, et al. Assessment of the role of histopathology and DNA image analysis in the diagnosis of molar and non-molar abortion: a study of 89 cases in the center of Tunisia. Pathol Res Pract. 2009; 205(11):789-796.
8. Grimes DA. Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol. 1984;150(3):309-318. (Pubitemid 14000357)
9. Bracken MB. Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol. 1987;94(12):1123-1135. (Pubitemid 18058551)
10. Steigrad SJ. Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003;17(6):837-847. (Pubitemid 38063139)
11. Parazzini F, Mangili G, LaVecchiaC, Negri E, Bocciolone L, Fasoli M. Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles. Obstet Gynecol. 1991;78(6):1039-1045.
12. Sand PK, Lurain JR, Brewer JL. Repeat gestational trophoblastic disease. Obstet Gynecol. 1984;63(2):140-144. (Pubitemid 14177242)
13. Parazzini F, LaVecchia C, Pampallona S. Parental age and risk of complete and partial hydatidiform mole. Br J Obstet Gynecol. 1986;93(6):582-585. (Pubitemid 16094090)
14. Berkowitz RS, Im SS, Bernstein MR, Goldstein DP. Gestational trophoblastic disease: subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med. 1998;43(1):81-86. (Pubitemid 28076690)
15. Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete molar pregnancy in relation to maternal age. Br J Obstet Gynecol. 2002;109(1):99-102.
16. Fisher RA, Hodges MD, Newlands ES. Familial recurrent hydatidiform mole: a review. J Reprod Med. 2004;49(8):595-601. (Pubitemid 39128773)
17. Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet. 1999;8(4):667-671. (Pubitemid 29139982)
18. Sensi A, Gualandi F, Pittalis MC, et al. Mole maker phenotype: possible narrowing ofthe candidate region. Eur J Hum Genet. 2000;8(8):641-644. (Pubitemid 30639372)
19. Panichkul PC, Al-Hussaini TK, Sierra R, et al. Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol investig. 2005;12(5):376-383. (Pubitemid 40848463)
20. Murdoch S, Djuric U, Mazhar B, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38(3):300-302.
21. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003;4(2):95-104. (Pubitemid 36172693)
22. Martinon F, GaideO, Pétrilli V, Mayor A, TschoppJ. NALP inflammasomes: a central role in innate immunity. Semin immunopathol. 2007;29(3):213-229. (Pubitemid 47416217)
23. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. J Biol Chem. 2005;280(23):21720-21725. (Pubitemid 40827818)
24. Krussel JS, Bielfeld P, Lake Polan M, Simon C. Regulation of embryonic implantation. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):S2-S9. (Pubitemid 37072136)
25. Kou YC, Shao L, Peng HH, et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod. 2008;14(1):33-40. (Pubitemid 351267224)
26. Deveault C, Qian JH, Chebaro W, et al. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet. 2009;18(5):888-897.
27. Wang CM, Dixon PH, Decordova S, et al. Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region. J Med Genet. 2009;46(8):569-575.
28. Hayward BE, De Vos M, Talati N, et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat. 2009;30(5):E629-E639.
29. Puechberty J, Rittore C, Philibert L, et al. Homozygous NLRP7 mutations in a Moroccan woman with recurrent reproductive failure. Clin Genet. 2009; 75(3):298-300.
30. Williams D, Hodgetts V, Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):3-7.
31. Landolsi H, Rittore C, Philibert L, et al. Screening for NLRP7 mutation in familial and sporadic recurrent hydatidiform moles: report of two Tunisian families. int J Gynecol Pathol. 2011;30(4):348-353.
32. Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29(6):803-808. (Pubitemid 351794131)
33. Qian J, Cheng Q, Murdoch S, et al. The genetics of recurrent hydatidiform moles in China: correlations between NLRP7 mutations, molar genotypes, and reproductive outcomes [published online ahead of print April 19, 2011]. Mol Hum Reprod. doi:10.1093/molehr/gar027.
34. Messaed C, Chebaro W, Roberto RB, et al. NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage. J Med Genet. 2011;48(8):540-548.
35. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology. 1996; 28(2):101-110.
36. Sumithran E, Cheah PL, Susil BJ, Looi LM. Problems in the histological assessment of hydatidiform moles: a study on consensus diagnosis and ploidy status by fluorescent in situ hybridization. Pathology. 1996;28(4):311-315. (Pubitemid 27170917)
37. Slim R, Ao A, Surti U, et al. Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations. Placenta. 2011;32(5):409-412.
38. Al-Hussaini TK, Abd el-Aal DM, Van den Veyver IB. Recurrent pregnancy loss due to familial and non-familial habitual molar pregnancy. int J Gynaecol Obstet. 2003;83(2):179-186. (Pubitemid 37194455)
39. Qian J, Deveault C, Bagga R, Xie X, Slim R. Women heterozygous for NALP7/NLRP7 mutations are at risk for reproductive wastage: report of two novel mutations. Hum Mutat. 2007;28(7):741.
40. Slim R, Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet. 2007;71(1):25-34. (Pubitemid 44921618)
41. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 2001;11(6):725-732. (Pubitemid 34076634)